Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the quick ratio (acid-test) high or low?
The quick ratio (acid-test) of 9.71 is 23% above its 5-year average of 7.91, near the low end of its 5-year range (2.07–31.15).
As of the fiscal period ended Tuesday, June 30, 2026. 87.34% above its 12-month average of 5.18.
Reported quarterly quick ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 9.71.
QUICK RATIO (ACID-TEST)
9.71
QUICK RATIO (ACID-TEST) AVG TTM
5.18
QUICK RATIO (ACID-TEST) AVG 3Y
5.33
QUICK RATIO (ACID-TEST) AVG 5Y
7.91
QUICK RATIO (ACID-TEST) AVG 10Y
N/A
QUICK RATIO (ACID-TEST) AVG 15Y
N/A
QUICK RATIO (ACID-TEST) AVG 20Y
N/A
CURRENT VS TTM AVG
+87.34%
CURRENT VS 3Y AVG
+82.13%
CURRENT VS 5Y AVG
+22.72%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
3.19
median of 759 covered companies
CURRENT VS SECTOR MEDIAN
+204.35%
vs the sector median at left
ALX Oncology Holdings Inc.
Market Cap
$153.40M
Quick Ratio (Acid-Test)
9.71
TTM Avg
5.18
3Y Avg
5.33
5Y Avg
7.91
Market Cap
$151.58M
Quick Ratio (Acid-Test)
5.55
TTM Avg
4.34
3Y Avg
4.83
5Y Avg
5.44
Market Cap
$151.12M
Quick Ratio (Acid-Test)
2.99
TTM Avg
3.92
3Y Avg
3.42
5Y Avg
4.30
Market Cap
$149.20M
Quick Ratio (Acid-Test)
15.62
TTM Avg
10.23
3Y Avg
11.93
5Y Avg
11.24
Market Cap
$148.43M
Quick Ratio (Acid-Test)
2.47
TTM Avg
5.26
3Y Avg
13.15
5Y Avg
16.36
Market Cap
$159.33M
Quick Ratio (Acid-Test)
20.14
TTM Avg
22.07
3Y Avg
21.46
5Y Avg
19.43
Market Cap
$148.77M
Quick Ratio (Acid-Test)
1.23
TTM Avg
1.14
3Y Avg
1.35
5Y Avg
4.96
Market Cap
$160.68M
Quick Ratio (Acid-Test)
1.70
TTM Avg
1.19
3Y Avg
1.52
5Y Avg
2.42
| NAME | MARKET CAP | QUICK RATIO (ACID-TEST) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| ALX Oncology Holdings Inc. (ALXO) | $153.40M | 9.71 | 5.18 | 5.33 | 7.91 |
| Cardiol Therapeutics Inc. (CRDL)vs › | $151.58M | 5.55 | 4.34 | 4.83 | 5.44 |
| Inogen, Inc. (INGN)vs › | $157.46M | 2.34 | 2.40 | 2.87 | 3.55 |
| Codexis, Inc. (CDXS)vs › | $151.12M | 2.99 | 3.92 | 3.42 | 4.30 |
| Anavex Life Sciences Corp. (AVXL)vs › | $149.20M | 15.62 | 10.23 | 11.93 | 11.24 |
| Acumen Pharmaceuticals, Inc. (ABOS)vs › | $148.43M | 2.47 | 5.26 | 13.15 | 16.36 |
| Minerva Neurosciences, Inc. (NERV)vs › | $159.33M | 20.14 | 22.07 | 21.46 | 19.43 |
| NervGen Pharma Corp. Common stock (NGEN)vs › | $148.77M | 1.23 | 1.14 | 1.35 | 4.96 |
| Coherus Oncology, Inc. (CHRS)vs › | $160.68M | 1.70 | 1.19 | 1.52 | 2.42 |
| PepGen Inc. (PEPG)vs › | $162.20M | 13.36 | 9.68 | 8.92 | 10.26 |
Quick Ratio
9.71
Excludes inventory
Current Ratio
9.71
Includes inventory
Quick Ratio = (Current Assets − Inventory) / Current Liabilities
The quick ratio is a stricter liquidity measure that excludes inventory, showing the ability to meet short-term obligations with the most liquid assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | QUICK RATIO (ACID-TEST) |
|---|---|
| 2026-06-30 | 9.71 |
| 2026-03-31 | 7.21 |
| 2025-12-31 | 2.07 |
| 2025-09-30 | 2.40 |
| 2025-06-30 | 4.52 |
| 2025-03-31 | 5.47 |
| 2024-12-31 | 7.26 |
| 2024-09-30 | 4.82 |
| 2024-06-30 | 4.39 |
| 2024-03-31 | 5.21 |
| 2023-12-31 | 5.24 |
| 2023-09-30 | 5.66 |
| 2023-06-30 | 12.49 |
| 2023-03-31 | 10.62 |
| 2022-12-31 | 9.57 |
| 2022-09-30 | 11.52 |
| 2022-06-30 | 13.23 |
| 2022-03-31 | 21.00 |
| 2021-12-31 | 24.00 |
| 2021-09-30 | 31.15 |
| 2021-06-30 | 29.49 |
| 2021-03-31 | 30.60 |
| 2020-12-31 | 70.28 |
| 2020-09-30 | 36.46 |
| 2020-06-30 | 13.04 |
| 2020-03-31 | 26.92 |
| 2019-12-31 | 1.97 |
| 2019-09-30 | 0.00 |
| 2019-06-30 | 0.00 |
| 2019-03-31 | 0.00 |
